Updated on 2026/10/03

写真a

 
Suzuki Ikuro
 
Organization
- - Professor
External link

Research Areas

  • Life Science / Neuroscience-general

Research History

  • Tohoku Institute of Technology   Professor

    2021.4

      More details

  • 東北工業大学 AiR研究所   所長

    2019.7

      More details

  • RIKEN

    2018.4

      More details

  • Tohoku Institute of Technology   Associate Professor

    2016.4 - 2021.3

      More details

  • Tohoku Institute of Technology   Lecturer

    2014.4 - 2016.3

      More details

  • Tokyo University of Technology   Assistant Professor

    2010.4 - 2014.3

      More details

  • Tokyo Medical and Dental University   Institute of Biomaterials and Bioengineering   Assistant Professor

    2008.4 - 2010.3

      More details

  • 日本学術振興会特別研究員DC1(東京大学)

    2005.4 - 2008.3

      More details

▼display all

Professional Memberships

  • 日本生体医工学会関東支部 評議員

    2023.1

      More details

  • 次世代医工学研究会 幹事

    2013.1 - 2019.3

      More details

Committee Memberships

  • 公益社団法人 電気化学会   電気化学会第90回大会 委員  

    2022.12 - 2023.3   

      More details

    Committee type:Academic society

    researchmap

  • 文部科学省   科学技術専門家ネットワーク 専門調査員  

    2019.7   

      More details

    Committee type:Government

    researchmap

  • ヒトiPS細胞応用安全性コンソーシアム   ヒトiPS細胞応用安全性コンソーシアム(CSAHi) 有識者会員  

    2016.1   

      More details

    Committee type:Academic society

    researchmap

Papers

  • In vitro and preclinical assessment of drug interactions between fluoroquinolones and a nonsteroidal antiinflammatory drug predicting risk of seizure Reviewed

    Yuki Seki, Ikue Mihara, Taroumaru Okawa, Atsuko Ojima, Kazumasa Aoyama, Masaki Mikamoto, Yuka Morimitsu, Takeo Kamakura, Yasuaki Goto, Aoi Odawara, Yukiko Oshiro, Tomohiko Taniguchi, Motohiro Shiotani, Takashi Yoshinaga, Shoji Asakura, Yuto Ishibashi, Naoki Matsuda, Ikuro Suzuki, Norimasa Miyamoto

    Toxicological Sciences   209 ( 5 )   2026.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Seizures are a common reason for drugs to fail during development, but they are difficult to predict preclinically. Enoxacin, a fluoroquinolone, rarely causes convulsions as a monotherapy, but convulsions have been seen after combination therapy with fenbufen, a nonsteroidal antiinflammatory drug. The interaction between the drugs is thought to result from inhibition of GABAA receptors, which are not their primary targets. Here, we show that, among 15 marketed fluoroquinolones and 1 active metabolite, 6, including enoxacin, inhibited γ-aminobutyric acid (GABA)-evoked depolarization in cells expressing human GABAA receptors when administered with felbinac, the active metabolite of fenbufen. Within these 6, except for a prodrug, possessed a piperazinyl group at the seventh position of the quinolone ring. We also administered enoxacin or norfloxacin plus felbinac to rats and determined the cerebrospinal fluid concentrations of each drug when convulsions occurred. As we previously reported, an increase in network burst frequency recorded from primary cultured rat cortical neurons on microelectrode arrays is a risk marker for seizures, so we tested whether this assay could predict seizures induced by drug interactions between fluoroquinolones and felbinac. When co-administered with felbinac, only those fluoroquinolones that inhibited GABA currents in patch-clamp tests increased network burst frequency. Principal component analysis using 17 microelectrode array parameters supported that the mechanism of action was due to GABA antagonism in rodent neurons. Thus, the microelectrode array assay predicted seizure risks from the combination of enoxacin and the active metabolite of fenbufen and identified other fluoroquinolones with seizure risk potential.

    DOI: 10.1093/toxsci/kfag039

    researchmap

    Other Link: https://academic.oup.com/toxsci/article-pdf/209/5/kfag039/67510793/kfag039.pdf

  • Development of a microelectrode array system for simultaneous measurement of field potential and glutamate release in brain slices Reviewed

    Aiko Hasegawa, Naoki Matsuda, Ikuro Suzuki

    Biosensors and Bioelectronics   287   117696 - 117696   2025.11

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bios.2025.117696

    researchmap

  • Advanced cardiotoxicity profiling using field potential imaging with UHD-CMOS-MEA in human iPSC-derived cardiomyocytes Reviewed

    Naoki Matsuda, Nami Nagafuku, Kazuki Matsuda, Yuto Ishibashi, Tomohiko Taniguchi, Yusaku Matsushita, Norimasa Miyamoto, Takashi Yoshinaga, Ikuro Suzuki

    Toxicological Sciences   208 ( 2 )   384 - 400   2025.9

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Accurate assessment of cardiotoxicity using human induced pluripotent stem cell (iPSC)-derived cardiomyocytes is critical for ensuring drug safety during preclinical development. However, existing in vitro methodologies predominantly focus on QT interval prolongation and arrhythmia risk, often lacking the capacity to capture the complex interplay among multiple ion channels or to detect early manifestations of chronic cardiotoxicity—both of which are essential for evaluating long-term cardiac safety. Moreover, reliable prediction of pharmacological mechanisms of action remains a significant challenge. In this study, we employed field potential imaging utilizing an ultra-high-density complementary metal–oxide–semiconductor microelectrode array (MEA) comprising 236,880 electrodes distributed across a 5.9 × 5.5 mm active area. With 91.9% surface coverage by 11 μm electrodes spaced at 0.25 μm, the platform achieves near single-cell resolution across the entire cardiomyocyte monolayer. This system enabled the extraction of high-resolution electrophysiological endpoints, including the number and spatial variability of excitation origins, conduction velocity, and propagation area—thereby extending the analytical capabilities beyond those of conventional MEAs. Pharmacological testing revealed compound-specific alterations: Isoproterenol increased excitation origins, mexiletine reduced conduction velocity, and E-4031 diminished propagation area. Although these agents are well characterized, their effects were visualized with unprecedented spatiotemporal resolution, reflecting their underlying mechanisms of action. Multivariate analysis incorporating both conventional and novel endpoints enabled accurate classification of mechanisms under acute conditions. Furthermore, chronic cardiotoxicity induced by low-dose doxorubicin (0.03 μM) was sensitively detected within 24 h—earlier and at lower concentrations than previously reported—based on significant reductions in conduction velocity and propagation area. Collectively, these findings establish a high-resolution, mechanism-aware framework for in vitro cardiotoxicity profiling, offering improved predictive accuracy by capturing multi-ion channel interactions, spatial conduction abnormalities, and early signs of chronic dysfunction.

    DOI: 10.1093/toxsci/kfaf134

    researchmap

    Other Link: https://academic.oup.com/toxsci/article-pdf/208/2/384/64455176/kfaf134.pdf

  • Advanced neural activity mapping in brain organoids via field potential imaging with ultra-high-density CMOS microelectrode arrays Reviewed

    Remi Yokoi, Naoki Matsuda, Yuto Ishibashi, Ikuro Suzuki

    Frontiers in Neuroscience   19   2025.8

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Introduction

    Human iPSC-derived brain organoids and assembloids have emerged as promising in vitro models for recapitulating human brain development, neurological disorders, and drug responses. However, detailed analysis of their electrophysiological properties requires advanced measurement techniques.

    Methods

    Here, we present an analytical approach using ultra-high-density (UHD) CMOS microelectrode arrays (MEAs) with 236,880 electrodes across a 32.45 mm2 sensing area, enabling large-scale field potential imaging (FPI) of brain organoids.

    Results

    Neuronal activity was recorded from over 46,000 electrodes, allowing single-cell spike detection and network connectivity analysis. In midbrain organoids, L-DOPA administration elicited both excitatory and inhibitory responses, with a dose-dependent shift toward network enhancement. Leveraging the spatiotemporal resolution of the UHD-CMOSMEA, we introduced two novel endpoints: propagation velocity and propagation area. In cortical organoids, picrotoxin increased propagation velocity, while MK-801 reduced propagation area. FPI also enabled frequency-domain analyses, revealing region-specific activity, including distinct gamma-band patterns. In midbrain–striatal assembloids, 4-aminopyridine enhanced interorganoid connectivity.

    Conclusion

    This single-cell-resolved, large-scale recording approach using UHD-CMOS MEAs enables detailed analysis of network connectivity, propagation dynamics, and frequency features. It provides a powerful platform for studying brain organoids and assembloids, with strong potential for drug discovery and disease modeling in human neuroscience.

    DOI: 10.3389/fnins.2025.1634582

    researchmap

  • Involvement of <scp>IL</scp>‐13‐Induced Dysregulation of <scp>BDNF</scp>‐<scp>NTRK2</scp> Pathway in Symptoms of Eosinophilic Esophagitis Reviewed

    Kasumi Osonoi, Akinari Sawada, Yuki Maekawa, Mari Yamaguchi, Shingo Yamada, Kazuhiro Matsuyama, Mark Rochman, Marc E. Rothenberg, Xiaobo Han, Naoki Matsuda, Ikuro Suzuki, Fumio Tanaka, Yasuhiro Fujiwara, Tetsuo Shoda

    Allergy   80 ( 10 )   2894 - 2897   2025.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/all.16592

    researchmap

  • <i>In vitro</i> seizure risk assessment using a microelectrode array and comparison with an <i>in vivo</i> rat study Reviewed

    Yuki Seki, Masaki Mikamoto, Atsuko Ojima, Ikue Mihara, Minako Iwamoto, Aoi Odawara, Yasuaki Goto, Tomohiko Taniguchi, Motohiro Shiotani, Takashi Yoshinaga, Shoji Asakura, Yuto Ishibashi, Naoki Matsuda, Ikuro Suzuki, Norimasa Miyamoto

    Toxicological Sciences   206 ( 1 )   202 - 217   2025.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Drug-induced convulsions/seizures are a serious adverse event in the clinic; however, precise convulsion/seizure risk assessment remains challenging, particularly in the early phase of drug development. There is a demand for reliable in vitro assay systems that can predict in vivo convulsions. Here, we investigated the usefulness of in vitro microelectrode array (MEA) assays using rat primary neurons by comparing them with an in vivo convulsion study for 14 reference drugs known to cause seizure/convulsion: Paroxetine, 4-aminopyridine, pentylenetetrazol, strychnine, amoxapine, fluvoxamine, linopirdine, theophylline, pilocarpine, tramadol, bupropion, diphenhydramine, kainic acid, and veratridine. For the in vitro assay, a culture condition was established that demonstrated stable firing rates and drug responses of neurons and ensured a balanced expression of excitatory and inhibitory neuronal markers. Cultured rat primary cortical neurons were tested by MEA for electrophysiological changes induced by drugs. An MEA parameter, network burst frequency (NBF), was increased in a concentration-dependent manner by some of the drugs tested, demonstrating reproducibility. Rats were intraperitoneally or intravenously given the drugs at doses that did and did not cause convulsions. Concentrations of the drugs in cerebrospinal fluid (CSF), obtained just after convulsion onset, were measured by LC-MS/MS. The NBF threshold for seizure could be used to predict the CSF concentrations of some drugs in rats with convulsions. Thus, an in vitro MEA assay using rat primary neurons can predict the risk of in vivo convulsions, which could be useful for drug screening during the early stage of drug candidate selection.

    DOI: 10.1093/toxsci/kfaf056

    researchmap

    Other Link: https://academic.oup.com/toxsci/article-pdf/206/1/202/63000764/kfaf056.pdf

  • Cardiac dysfunction due to mitochondrial impairment assessed by human iPS cells caused by DNM1L mutations Reviewed

    Madori T. Osawa, Yasunori Fujita, Kazuki Kagami, Masataka Ito, Yoshiteru Tamura, Shoichiro Tateishi, Junya Take, Fumi Hirose, Hidetoshi Hagiwara, Kohsuke Imai, Daisuke Yoshinaga, Shiro Baba, Mitsujiro Osawa, Hiroko Harashima, Kei Murayama, Yuko Akioka, Akira Ohtake, Ikuro Suzuki, Takeshi Adachi, Takeru Yamazaki, Satoshi Arai, Shiro Matsumoto, Tetsuya Kitaguchi, Megumu K. Saito, Ikuroh Ohsawa, Shigeaki Nonoyama

    Pediatric Research   98 ( 5 )   1929 - 1940   2025.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Background

    DNM1L encodes dynamin-related protein 1, which plays an important role in mitochondrial and peroxisomal division. The DNM1L mutation leads to cardiac dysfunction in patients and animal models. However, the mechanism of cardiac dysfunction caused by DNM1L mutation has not been elucidated clearly at least in the studies of human cardiomyocytes.

    Methods

    We established human induced pluripotent stem cells (hiPSCs) from two pediatric patients with DNM1L mutation. The hiPSCs were differentiated into hiPSC-derived cardiomyocytes (hiPS-CMs). Mitochondrial morphology and function, cardiomyocyte Ca <sup>2+</sup> dynamics, and contractile and diastolic function of hiPS-CMs were analyzed.

    Results

    The morphology of the mitochondria was abnormally elongated in patient-derived hiPS-CMs. The mitochondrial membrane potential and oxygen consumption rate were significantly decreased, resulting in reduced ATP production. In the analysis of Ca <sup>2+</sup> dynamics, the 50% time to decay was significantly longer in patient-derived hiPS-CMs than in healthy control. High-precision live-imaging system analysis revealed that contractile and diastolic function was significantly impaired under isoproterenol stimulation.

    Conclusion

    DNM1L mutations cause mitochondrial impairment with less production of ATP in cardiomyocytes. This leads to abnormal intracellular Ca <sup>2+</sup> dynamics, resulting in contractile and diastolic dysfunction.

    Impact

    DNM1L mutations was identified in two pediatric patients who developed cardiac dysfunction and human induced pluripotent stem cells (hiPSCs) were established from these two patients and differentiated into hiPSC-derived cardiomyocytes (hiPS-CMs).

    DNM1L mutations induced abnormal mitochondrial morphology, mitochondrial dysfunction, and insufficient ATP production in hiPS-CMs. In addition, hiPS-CMs with DNM1L mutation showed abnormal Ca <sup>2+</sup> kinetics and impaired contractile and diastolic function.

    This is the first study that elucidate the mechanism of cardiac dysfunction caused by DNM1L mutations by using hiPSCs.

    DOI: 10.1038/s41390-025-04045-6

    researchmap

    Other Link: https://www.nature.com/articles/s41390-025-04045-6

  • Analysis of β rhythm induction in acute brain slices using field potential imaging with ultra-high-density CMOS-based microelectrode array

    Hiroto Takahashi, Naoki Matsuda, Ikuro Suzuki

    2025.4

     More details

    Authorship:Last author   Language:English   Publisher:openRxiv  

    Abstract

    Carbachol-induced beta rhythms in acute brain slices provide a promising ex vivo platform for evaluating compound effects under arousal-like hippocampal activity. Although microelectrode array (MEA) systems offer a non-invasive means of recording network dynamics, conventional MEAs have been limited by low electrode counts and small sensing areas, allowing only fragmented evaluation of neural activity. In this study, we applied field potential imaging (FPI) using an ultra-high-density (UHD) CMOS-MEA comprising 236,880 electrodes to simultaneously and spatially resolve carbachol-induced activity changes in the hippocampus and neocortex. Treatment with 10 µM carbachol reliably induced oscillatory activity in the hippocampus at 1.33 ± 0.33 Hz. Repetitive and temporally precise firing patterns originated in the CA3 region and propagated toward CA1. The average duration of individual oscillatory events was 52.82 ± 6.44 ms, corresponding to a frequency of 18.93 ± 3.03 Hz—within the beta frequency band. Cluster analysis based on waveform morphology revealed spatial groupings that reflected underlying anatomical structures. Beta-band power was significantly enhanced in both hippocampal and cortical regions following carbachol treatment. These findings demonstrate that the FPI platform enables high-resolution mapping of relationships between anatomical structures and brain function in acute slices, and holds promise as a pharmacological evaluation tool for assessing compound effects on hippocampal and cortical networks under wakefulness-like conditions.

    DOI: 10.1101/2025.03.30.646248

    researchmap

  • Analysis of β rhythm induction in acute brain slices using field potential imaging with UHD-CMOS-MEA

    Hiroto Takahashi, Naoki Matsuda, Ikuro Suzuki

    bioRxiv   2025.3

     More details

    Authorship:Last author   Language:English  

    researchmap

  • Development of a Novel Microphysiological System for Peripheral Neurotoxicity Prediction Using Human iPSC-Derived Neurons with Morphological Deep Learning Reviewed

    Xiaobo Han, Naoki Matsuda, Makoto Yamanaka, Ikuro Suzuki

    Toxics   12 ( 11 )   809 - 809   2024.11

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    A microphysiological system (MPS) is an in vitro culture technology that reproduces the physiological microenvironment and functionality of humans and is expected to be applied for drug screening. In this study, we developed an MPS for the structured culture of human iPSC-derived sensory neurons and then predicted drug-induced neurotoxicity by morphological deep learning. Using human iPSC-derived sensory neurons, after the administration of representative anti-cancer drugs, the toxic effects on soma and axons were evaluated by an AI model with neurite images. Significant toxicity was detected in positive drugs and could be classified by different effects on soma or axons, suggesting that the current method provides an effective evaluation of chemotherapy-induced peripheral neuropathy. The results of neurofilament light chain expression changes in the MPS device also agreed with clinical reports. Therefore, the present MPS combined with morphological deep learning is a useful platform for in vitro peripheral neurotoxicity assessment.

    DOI: 10.3390/toxics12110809

    researchmap

  • Development of an evaluation method for addictive compounds based on electrical activity of human iPS cell‐derived dopaminergic neurons using microelectrode array Reviewed

    Yuto Ishibashi, Nami Nagafuku, Shingo Kimura, Xiaobo Han, Ikuro Suzuki

    Addiction Biology   29 ( 10 )   e13443 - e13443   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Addiction is known to occur through the consumption of substances such as pharmaceuticals, illicit drugs, food, alcohol and tobacco. These addictions can be viewed as drug addiction, resulting from the ingestion of chemical substances contained in them. Multiple neural networks, including the reward system, anti‐reward/stress system and central immune system in the brain, are believed to be involved in the onset of drug addiction. Although various compound evaluations using microelectrode array (MEA) as an in vitro testing methods to evaluate neural activities have been conducted, methods for assessing addiction have not been established. In this study, we aimed to develop an in vitro method for assessing the addiction of compounds, as an alternative to animal experiments, using human iPS cell‐derived dopaminergic neurons with MEA measurements. MEA data before and after chronic exposure revealed specific changes in addictive compounds compared to non‐addictive compounds, demonstrating the ability to estimate addiction of compound. Additionally, conducting gene expression analysis on cultured samples after the tests revealed changes in the expression levels of various receptors (nicotine, dopamine and GABA) due to chronic administration of addictive compounds, suggesting the potential interpretation of these expression changes as addiction‐like responses in MEA measurements. The addiction assessment method using MEA measurements in human iPS cell‐derived dopaminergic neurons conducted in this study proves effective in evaluating addiction of compounds on human neural networks.

    DOI: 10.1111/adb.13443

    researchmap

  • Induced pluripotent stem cell-derived neural stem cells promote bone formation in mice with calvarial defects Reviewed

    Yukari Shiwaku, Hiroko Okawa, Ikuro Suzuki, Susumu Sakai, Hiroshi Egusa, Osamu Suzuki

    Acta Biomaterialia   188 ( 1 )   93 - 102   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.actbio.2024.08.054

    researchmap

  • An In Vitro Assessment Method for Chemotherapy-Induced Peripheral Neurotoxicity Caused by Anti-Cancer Drugs Based on Electrical Measurement of Impedance Value and Spontaneous Activity Reviewed

    Xiaobo Han, Naoki Matsuda, Yuto Ishibashi, Mikako Shibata, Ikuro Suzuki

    Pharmaceutics   15 ( 12 )   2788 - 2788   2023.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major adverse event of anti-cancer drugs, which still lack standardized measurement and treatment methods. In the present study, we attempted to evaluate neuronal dysfunctions in cultured rodent primary peripheral neurons using a microelectrode array system. After exposure to typical anti-cancer drugs (i.e., paclitaxel, vincristine, oxaliplatin, and bortezomib), we successfully detected neurotoxicity in dorsal root ganglia neurons by measuring electrical activities, including impedance value and spontaneous activity. The impedance value decreased significantly for all compounds, even at low concentrations, which indicated cell loss and/or neurite degeneration. The spontaneous activity was also suppressed after exposure, which suggested neurotoxicity again. However, an acute response was observed for paclitaxel and bortezomib before toxicity, which showed different mechanisms based on compounds. Therefore, MEA measurement of impedance value could provide a simple assessment method for CIPN, combined with neuronal morphological changes.

    DOI: 10.3390/pharmaceutics15122788

    researchmap

  • Evaluation of neurotoxicity for pesticide-related compounds in human iPS cell-derived neurons using microelectrode array

    Yuto Ishibashi, Nami Nagafuku, Yasunari Kanda, Ikuro Suzuki

    Toxicology in Vitro   93   105668 - 105668   2023.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.tiv.2023.105668

    researchmap

  • Large-area field potential imaging having single neuron resolution using 236,880 electrodes CMOS-MEA technology Reviewed

    I. Suzuki, N. Matsuda, X. Han, S. Noji, M. Shibata, N. Nagafuku, Y. Ishibashi

    Advanced Science   10 ( 20 )   1 - 23   2023.11

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    researchmap

  • Contraindicated Drug Responses in Dravet Syndrome Brain Organoids Utilizing Micro Electrode Array Assessment Methods Reviewed

    Remi Yokoi, Nami Nagafuku, Yuto Ishibashi, Naoki Matsuda, Ikuro Suzuki

    Organoids   2 ( 4 )   177 - 191   2023.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Ensuring drug safety for patients with specific neurological disorders is of paramount importance. For instance, certain antiepileptic drugs (AEDs) are contraindicated in Dravet Syndrome (DS), which is characterized by a deficiency in Na+ channel function. Constructing in vitro assessment methods capable of detecting contraindicated drug responses and medication effects on neurons derived from DS patients is highly anticipated for drug safety assessment and therapeutic innovation. This study used micro electrode array (MEA) measurements with low-frequency analysis on human iPSC-derived DS organoids to investigate AED responses. When exposed to the contraindicated drugs carbamazepine and phenytoin, the number of network oscillations increased in DS organoids while maintaining oscillation intensity. Furthermore, carbamazepine administration appeared to enhance activities beyond oscillations which is partially consistent with findings in the DS mouse model. Conversely, treatment with the therapeutic drug sodium valproate resulted in a similar decrease in activity both in healthy and DS organoids. The frequency characteristics of spontaneous firings and AEDs responsiveness in DS organoids demonstrated partial correlation with typical electroencephalography patterns observed in vivo. In conclusion, this study, employing MEA measurements with low-frequency analysis, revealed contraindicated drug responses and disease-specific functional characteristics in DS organoids, effective for DS patient safety assessment, precision medicine, and antiepileptic drug screening.

    DOI: 10.3390/organoids2040014

    researchmap

  • Development of an In Vitro Assessment Method for Chemotherapy-Induced Peripheral Neuropathy (CIPN) by Integrating a Microphysiological System (MPS) with Morphological Deep Learning of Soma and Axonal Images Reviewed

    Kazuki Matsuda, Xiaobo Han, Naoki Matsuda, Makoto Yamanaka, Ikuro Suzuki

    Toxics   11 ( 10 )   848 - 848   2023.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Several anticancer drugs used in cancer therapy induce chemotherapy-induced peripheral neuropathy (CIPN), leading to dose reduction or therapy cessation. Consequently, there is a demand for an in vitro assessment method to predict CIPN and mechanisms of action (MoA) in drug candidate compounds. In this study, a method assessing the toxic effects of anticancer drugs on soma and axons using deep learning image analysis is developed, culturing primary rat dorsal root ganglion neurons with a microphysiological system (MPS) that separates soma from neural processes and training two artificial intelligence (AI) models on soma and axonal area images. Exposing the control compound DMSO, negative compound sucrose, and known CIPN-causing drugs (paclitaxel, vincristine, oxaliplatin, suramin, bortezomib) for 24 h, results show the somatic area-learning AI detected significant cytotoxicity for paclitaxel (* p &lt; 0.05) and oxaliplatin (* p &lt; 0.05). In addition, axonal area-learning AI detected significant axonopathy with paclitaxel (* p &lt; 0.05) and vincristine (* p &lt; 0.05). Combining these models, we detected significant toxicity in all CIPN-causing drugs (** p &lt; 0.01) and could classify anticancer drugs based on their different MoA on neurons, suggesting that the combination of MPS-based culture segregating soma and axonal areas and AI image analysis of each area provides an effective evaluation method to predict CIPN from low concentrations and infer the MoA.

    DOI: 10.3390/toxics11100848

    researchmap

  • Verification of the seizure liability of compounds based on their in vitro functional activity in cultured rat cortical neurons and co-cultured human iPSC-derived neurons with astrocytes and in vivo extrapolation to cerebrospinal fluid concentration Reviewed

    Y. Ishibashi, N. Nagafuku, K. Kinoshita, A. Okamura, T. Shirakawa, I. Suzuki

    Toxicology and Applied Pharmacology   476   116675 - 116675   2023.10

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.taap.2023.116675

    researchmap

  • Neuroprotective Potential of L-Glutamate Transporters in Human Induced Pluripotent Stem Cell-Derived Neural Cells against Excitotoxicity Reviewed

    Kanako Takahashi, Yuto Ishibashi, Kaori Chujo, Ikuro Suzuki, Kaoru Sato

    International Journal of Molecular Sciences   24 ( 16 )   12605 - 12605   2023.8

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Human induced pluripotent stem cell (hiPSC)-derived neural cells have started to be used in safety/toxicity tests at the preclinical stage of drug development. As previously reported, hiPSC-derived neurons exhibit greater tolerance to excitotoxicity than those of primary cultures of rodent neurons; however, the underlying mechanisms remain unknown. We here investigated the functions of L-glutamate (L-Glu) transporters, the most important machinery to maintain low extracellular L-Glu concentrations, in hiPSC-derived neural cells. We also clarified the contribution of respective L-Glu transporter subtypes. At 63 days in vitro (DIV), we detected neuronal circuit functions in hiPSC-derived neural cells by a microelectrode array system (MEA). At 63 DIV, exposure to 100 μM L-Glu for 24 h did not affect the viability of neural cells. 100 µM L-Glu in the medium decreased to almost 0 μM in 60 min. Pharmacological inhibition of excitatory amino acid transporter 1 (EAAT1) and EAAT2 suppressed almost 100% of L-Glu decrease. In the presence of this inhibitor, 100 μM L-Glu dramatically decreased cell viability. These results suggest that in hiPSC-derived neural cells, EAAT1 and EAAT2 are the predominant L-Glu transporters, and their uptake potentials are the reasons for the tolerance of hiPSC-derived neurons to excitotoxicity.

    DOI: 10.3390/ijms241612605

    researchmap

  • Large‐Area Field Potential Imaging Having Single Neuron Resolution Using 236 880 Electrodes CMOS‐MEA Technology Reviewed

    Ikuro Suzuki, Naoki Matsuda, Xiaobo Han, Shuhei Noji, Mikako Shibata, Nami Nagafuku, Yuto Ishibashi

    Advanced Science   10 ( 20 )   2023.4

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    The electrophysiological technology having a high spatiotemporal resolution at the single‐cell level and noninvasive measurements of large areas provide insights on underlying neuronal function. Here, a complementary metal‐oxide semiconductor (CMOS)‐microelectrode array (MEA) is used that uses 236 880 electrodes each with an electrode size of 11.22 × 11.22 µm and 236 880 covering a wide area of 5.5 × 5.9 mm in presenting a detailed and single‐cell‐level neural activity analysis platform for brain slices, human iPS cell‐derived cortical networks, peripheral neurons, and human brain organoids. Propagation pattern characteristics between brain regions changes the synaptic propagation into compounds based on single‐cell time‐series patterns, classification based on single DRG neuron firing patterns and compound responses, axonal conduction characteristics and changes to anticancer drugs, and network activities and transition to compounds in brain organoids are extracted. This detailed analysis of neural activity at the single‐cell level using the CMOS‐MEA provides a new understanding of the basic mechanisms of brain circuits in vitro and ex vivo, on human neurological diseases for drug discovery, and compound toxicity assessment.

    DOI: 10.1002/advs.202207732

    researchmap

  • Detection of astrocytic slow oscillatory activity and response to seizurogenic compounds using planar microelectrode array Reviewed

    Taeko Kuroda, Naoki Matsuda, Yuto Ishibashi, Ikuro Suzuki

    Frontiers in Neuroscience   16   2023.1

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    Since the development of the planar microelectrode array (MEA), it has become popular to evaluate compounds based on the electrical activity of rodent and human induced pluripotent stem cell (iPSC)-derived neurons. However, there are no reports recording spontaneous human astrocyte activity from astrocyte-only culture sample by MEA. It is becoming clear that astrocytes play an important role in various neurological diseases, and astrocytes are expected to be excellent candidates for targeted therapeutics for the treatment of neurological diseases. Therefore, measuring astrocyte activity is very important for drug development for astrocytes. Recently, astrocyte activity has been found to be reflected in the low-frequency band &amp;lt; 1 Hz, which is much lower than the frequency band for recording neural activity. Here, we separated the signals obtained from human primary astrocytes cultured on MEA into seven frequency bands and successfully recorded the extracellular electrical activity of human astrocytes. The slow waveforms of spontaneous astrocyte activity were observed most clearly in direct current potentials &amp;lt; 1 Hz. We established nine parameters to assess astrocyte activity and evaluated five seizurogenic drug responses in human primary astrocytes and human iPSC-derived astrocytes. Astrocytes demonstrated the most significant dose-dependent changes in pilocarpine. Furthermore, in a principal component analysis using those parameter sets, the drug responses to each seizurogenic compound were separated. In this paper, we report the spontaneous electrical activity measurement of astrocytes alone using MEA for the first time and propose that the MEA measurement focusing on the low-frequency band could be useful as one of the methods to assess drug response in vitro.

    DOI: 10.3389/fnins.2022.1050150

    researchmap

  • 雪質に合ったスノーワックス選定AIの開発とターンにおけるスノーボード軌跡情報の数値化

    鈴木郁郎

    地域連携センター・研究支援センター紀要   35 ( 1 )   61 - 69   2023.1

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese   Publishing type:Research paper (bulletin of university, research institution)  

    researchmap

  • Large-area electrical imaging having single neuron resolution using 236,880 electrodes CMOS-MEA technology

    I. Suzuki, N. Matsuda, X. Han, S. Noji, M. Shibata, N. Nagafuku, Y. Ishibashi

    bioRxiv   11 ( 9 )   515884   2022.11

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:openRxiv  

    Abstract

    The electrophysiological technology having a high spatio-temporal resolution at the single-cell level, and noninvasive measurements of large areas provides insights on underlying neuronal function. Here, we used a complementary metal-oxide semiconductor (CMOS)-microelectrode array (MEA) that uses 236,880 electrodes each with an electrode size of 11.22 × 11.22 µm and 236,880 covering a wide area of 5.5 × 5.7 mm in presenting a detailed and single-cell-level neural activity analysis platform for brain slices, human iPS cell-derived cortical networks, peripheral neurons, and human brain organoids. Propagation pattern characteristics between brain regions changes the synaptic strength into compounds based on single-cell time-series patterns, classification based on single DRG neuron firing patterns and compound responses, axonal conduction characteristics and changes to anticancer drugs, and network activities and transition to compounds in brain organoids were extracted. This detailed analysis of neural activity at the single-cell level using our CMOS-MEA provides a new understanding the basic mechanisms of brain circuits in vitro and ex vivo , on human neurological diseases for drug discovery, and compound toxicity assessment.

    DOI: 10.1101/2022.11.09.515884

    researchmap

  • A functional neuron maturation device provides convenient application on microelectrode array for neural network measurement Reviewed

    Xiaobo Han, Naoki Matsuda, Yuto Ishibashi, Aoi Odawara, Sayuri Takahashi, Norie Tooi, Koshi Kinoshita, Ikuro Suzuki

    Biomaterials Research   26 ( 1 )   2022.9

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:American Association for the Advancement of Science (AAAS)  

    Abstract

    Background

    Microelectrode array (MEA) systems are valuable for in vitro assessment of neurotoxicity and drug efficiency. However, several difficulties such as protracted functional maturation and high experimental costs hinder the use of MEA analysis requiring human induced pluripotent stem cells (hiPSCs). Neural network functional parameters are also needed for in vitro to in vivo extrapolation.

    Methods

    In the present study, we produced a cost effective nanofiber culture platform, the SCAD device, for long-term culture of hiPSC-derived neurons and primary peripheral neurons. The notable advantage of SCAD device is convenient application on multiple MEA systems for neuron functional analysis.

    Results

    We showed that the SCAD device could promote functional maturation of cultured hiPSC-derived neurons, and neurons responded appropriately to convulsant agents. Furthermore, we successfully analyzed parameters for in vitro to in vivo extrapolation, i.e., low-frequency components and synaptic propagation velocity of the signal, potentially reflecting neural network functions from neurons cultured on SCAD device. Finally, we measured the axonal conduction velocity of peripheral neurons. Conclusions: Neurons cultured on SCAD devices might constitute a reliable in vitro platform to investigate neuron functions, drug efficacy and toxicity, and neuropathological mechanisms by MEA.

    DOI: 10.1186/s40824-022-00324-z

    researchmap

    Other Link: https://link.springer.com/article/10.1186/s40824-022-00324-z/fulltext.html

  • <i>In Vitro</i> Pain Assay Using Human iPSC-Derived Sensory Neurons and Microelectrode Array

    Aoi Odawara, Mikako Shibata, Yuto Ishibashi, Nami Nagafuku, Naoki Matsuda, Ikuro Suzuki

    Toxicological Sciences   188 ( 1 )   131 - 141   2022.4

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Drug-induced peripheral neuropathy occurs as an adverse reaction of chemotherapy. However, a highly accurate method for assessing peripheral neuropathy and pain caused by compounds has not been established. The use of human-induced pluripotent stem cell (hiPSC)-derived sensory neurons does not require animal experiments, and it is considered an effective method that can approach extrapolation to humans. In this study, we evaluated the response to pain-related compounds based on neural activities using in vitro microelectrode array (MEA) measurements in hiPSC-derived sensory neurons. Cultured sensory neurons exhibited gene expression of the Nav1.7, TRPV1, TRPA1, and TRPM8 channels, which are typical pain-related channels. Channel-dependent evoked responses were detected using the TRPV1 agonist capsaicin, a TRPA1 agonist, allyl isothiocyanate (AITC), and TRPM8 agonist menthol. In addition, the firing frequency increased with an increase in temperature from 37°C to 46°C, and temperature sensitivity was observed. In addition, the temperature of the peak firing rate differed among individual neurons. Next, we focused on the increase in cold sensitivity, which is a side effect of the anticancer drug oxaliplatin, and evaluated the response to AITC in the presence and absence of oxaliplatin. The response to AITC increased in the presence of oxaliplatin in a concentration-dependent manner, suggesting that the increased cold sensitivity in humans can be reproduced in cultured hiPSC-derived sensory neurons. The in vitro MEA system using hiPSC-derived sensory neurons is an alternative method to animal experiments, and it is anticipated as a method for evaluating peripheral neuropathy and pain induced by compounds.

    DOI: 10.1093/toxsci/kfac045

    researchmap

    Other Link: https://academic.oup.com/toxsci/article-pdf/188/1/131/45940430/kfac045.pdf

  • Raster plots machine learning to predict the seizure liability of drugs and to identify drugs Reviewed

    N. Matsuda, A. Odawara, K. Kinoshita, A. Okamura, T. Shirakawa, I. Suzuki

    Scientific Reports   12 ( 1 )   2022.2

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    In vitro microelectrode array (MEA) assessment using human induced pluripotent stem cell (iPSC)-derived neurons holds promise as a method of seizure and toxicity evaluation. However, there are still issues surrounding the analysis methods used to predict seizure and toxicity liability as well as drug mechanisms of action. In the present study, we developed an artificial intelligence (AI) capable of predicting the seizure liability of drugs and identifying drugs using deep learning based on raster plots of neural network activity. The seizure liability prediction AI had a prediction accuracy of 98.4% for the drugs used to train it, classifying them correctly based on their responses as either seizure-causing compounds or seizure-free compounds. The AI also made concentration-dependent judgments of the seizure liability of drugs that it was not trained on. In addition, the drug identification AI implemented using the leave-one-sample-out scheme could distinguish among 13 seizure-causing compounds as well as seizure-free compound responses, with a mean accuracy of 99.9 ± 0.1% for all drugs. These AI prediction models are able to identify seizure liability concentration-dependence, rank the level of seizure liability based on the seizure liability probability, and identify the mechanism of the action of compounds. This holds promise for the future of in vitro MEA assessment as a powerful, high-accuracy new seizure liability prediction method.

    DOI: 10.1038/s41598-022-05697-8

    researchmap

    Other Link: https://www.nature.com/articles/s41598-022-05697-8

  • Electrophysiological responses to seizurogenic compounds dependent on E/I balance in human iPSC-derived cortical neural networks Reviewed

    R. Yokoi, T. Shigemoto-Kuroda, N. Matsuda, A. Odawara, I. Suzuki

    Journal of Pharmacological Sciences   148 ( 2 )   267 - 278   2022.2

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.jphs.2021.12.006

    researchmap

  • Responses to antibiotics in human iPSC-derived neurons based on the clinical antibiotic-associated encephalopathy classification Reviewed

    Yuto Ishibashi, Shingo Kimura, Ikuro Suzuki

    The Journal of Toxicological Sciences   47 ( 10 )   429 - 437   2022

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Society of Toxicology  

    DOI: 10.2131/jts.47.429

    researchmap

  • An &lt;i&gt;in vitro&lt;/i&gt; microfluidic culture device for peripheral neurotoxicity prediction at low concentrations based on deep learning Reviewed

    Xiaobo Han, Naoki Matsuda, Kazuki Matsuda, Makoto Yamanaka, Ikuro Suzuki

    Fundamental Toxicological Sciences   9 ( 7 )   203 - 209   2022

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Society of Toxicology  

    DOI: 10.2131/fts.9.203

    researchmap

  • Analysis of signal components &lt; 500 Hz in brain organoids coupled to microelectrode arrays: A reliable test-bed for preclinical seizure liability assessment of drugs and screening of antiepileptic drugs Reviewed

    R. Yokoi, M. Shibata, A. Odawara, Y. Ishibashi, N. Nagafuku, N. Matsuda, I. Suzuki

    Biochemistry and Biophysics Reports   28   101148 - 101148   2021.12

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrep.2021.101148

    researchmap

  • Principal Component Analysis to Distinguish Seizure Liability of Drugs in Human iPS Cell-Derived Neurons Reviewed

    Y Ishibashi, A Odawara, K Kinoshita, A Okamura, T Shirakawa, I Suzuki

    Toxicological Sciences   184 ( 2 )   265 - 275   2021.9

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Screening for drug discovery targeting the central nervous system requires the establishment of efficient and highly accurate toxicity test methods that can reduce costs and time while maintaining high throughput using the function of an in vitro neural network. In particular, an evaluation system using a human-derived neural network is desirable in terms of species difference. Despite the attention, the microelectrode array (MEA) is attracting among the evaluation systems that can measure in vitro neural activity, an effective analysis method for evaluation of toxicity and mechanism of action has not yet been established. Here we established analytical parameters and multivariate analysis method capable of detecting seizure liability of drugs using MEA measurement of human iPS cell-derived neurons. Using the spike time series data of all drugs, we established periodicity as a new analytical parameter. Periodicity has facilitated the detection of responses to seizurogenic drugs, previously difficult to detect with conventional analytical parameters. By constructing a multivariate analytical method that identifies a parameter set that achieves an arbitrary condition, we found that the parameter set comprising total spikes, maximum frequency (MF), inter- MF interval (IMFI), coefficient of variance of IMFI, and periodicity can uniformly detect the seizure liability of seizurogenic drugs with different mechanisms of action. Seizurogenic drugs were suggested to increase the regularity of the network burst in MEA measurements in human iPS cell-derived neurons.

    DOI: 10.1093/toxsci/kfab116

    researchmap

    Other Link: https://academic.oup.com/toxsci/article-pdf/184/2/265/41325219/kfab116.pdf

  • Histograms of Frequency-Intensity Distribution Deep Learning to Predict the Seizure Liability of Drugs in Electroencephalography Reviewed

    Naoki Matsuda, Kenichi Kinoshita, Ai Okamura, Takafumi Shirakawa, Ikuro Suzuki

    Toxicological Sciences   182 ( 2 )   229 - 242   2021.5

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Detection of seizures as well as that of seizure auras is effective in improving the predictive accuracy of seizure liability of drugs. Whereas electroencephalography has been known to be effective for the detection of seizure liability, no established methods are available for the detection of seizure auras. We developed a method for detecting seizure auras through machine learning using frequency-characteristic images of electroencephalograms. Histograms of frequency-intensity distribution prepared from electroencephalograms of rats analyzed during seizures induced with 4-aminopyridine (6 mg/kg), strychnine (3 mg/kg), and pilocarpine (400 mg/kg), were used to create an artificial intelligence (AI) system that learned the features of frequency-characteristic images during seizures. The AI system detected seizure states learned in advance with 100% accuracy induced even by convulsants acting through different mechanisms, and the risk of seizure before a seizure was detected in general observation. The developed AI system determined that the unlearned convulsant Tramadol (150 mg/kg) was the risk of seizure and the negative compounds aspirin and vehicle were negative. Moreover, the AI system detected seizure liability even in electroencephalography data associated with the use of 4-aminopyridine (3 mg/kg), strychnine (1 mg/kg), and pilocarpine (150 mg/kg), which did not induce seizures detectable in general observation. These results suggest that the AI system developed herein is an effective means for electroencephalographic detection of seizure auras, raising expectations for its practical use as a new analytical method that allows for the sensitive detection of seizure liability of drugs that has been overlooked previously in preclinical studies.

    DOI: 10.1093/toxsci/kfab061

    researchmap

    Other Link: http://academic.oup.com/toxsci/article-pdf/182/2/229/39557046/kfab061.pdf

  • Can We Panelize Seizure?

    Ruth Roberts, Simon Authier, R Daniel Mellon, Michael Morton, Ikuro Suzuki, Ronald B Tjalkens, Jean-Pierre Valentin, Jennifer B Pierson

    Toxicological Sciences   179 ( 1 )   3 - 13   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Seizure liability remains a significant cause of attrition in drug discovery and development, leading to loss of competitiveness, delays, and increased costs. Current detection methods rely on observations made in in vivo studies intended to support clinical trials, such as tremors or other abnormal movements. These signs could be missed or misinterpreted; thus, definitive confirmation of drug-induced seizure requires a follow-up electroencephalogram study. There has been progress in in vivo detection of seizure using automated video systems that record and analyze animal movements. Nonetheless, it would be preferable to have earlier prediction of seizurogenic risk that could be used to eliminate liabilities early in discovery while there are options for medicinal chemists making potential new drugs. Attrition due to cardiac adverse events has benefited from routine early screening; could we reduce attrition due to seizure using a similar approach? Specifically, microelectrode arrays could be used to detect potential seizurogenic signals in stem-cell-derived neurons. In addition, there is clear evidence implicating neuronal voltage-gated and ligand-gated ion channels, GPCRs and transporters in seizure. Interactions with surrounding glial cells during states of stress or inflammation can also modulate ion channel function in neurons, adding to the challenge of seizure prediction. It is timely to evaluate the opportunity to develop an in vitro assessment of seizure linked to a panel of ion channel assays that predict seizure, with the aim of influencing structure-activity relationship at the design stage and eliminating compounds predicted to be associated with pro-seizurogenic state.

    DOI: 10.1093/toxsci/kfaa167

    researchmap

    Other Link: http://academic.oup.com/toxsci/article-pdf/179/1/3/40420388/kfaa167.pdf

  • Versatile live-cell activity analysis platform for characterization of neuronal dynamics at single-cell and network level Reviewed

    Xinyue Yuan, Manuel Schröter, Marie Engelene J. Obien, Michele Fiscella, Wei Gong, Tetsuhiro Kikuchi, Aoi Odawara, Shuhei Noji, Ikuro Suzuki, Jun Takahashi, Andreas Hierlemann, Urs Frey

    Nature Communications   11 ( 1 )   2020.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Chronic imaging of neuronal networks in vitro has provided fundamental insights into mechanisms underlying neuronal function. Current labeling and optical imaging methods, however, cannot be used for continuous and long-term recordings of the dynamics and evolution of neuronal networks, as fluorescent indicators can cause phototoxicity. Here, we introduce a versatile platform for label-free, comprehensive and detailed electrophysiological live-cell imaging of various neurogenic cells and tissues over extended time scales. We report on a dual-mode high-density microelectrode array, which can simultaneously record in (i) full-frame mode with 19,584 recording sites and (ii) high-signal-to-noise mode with 246 channels. We set out to demonstrate the capabilities of this platform with recordings from primary and iPSC-derived neuronal cultures and tissue preparations over several weeks, providing detailed morpho-electrical phenotypic parameters at subcellular, cellular and network level. Moreover, we develop reliable analysis tools, which drastically increase the throughput to infer axonal morphology and conduction speed.

    DOI: 10.1038/s41467-020-18620-4

    researchmap

    Other Link: https://www.nature.com/articles/s41467-020-18620-4

  • Approach to Neurotoxicity using Human iPSC Neurons: Consortium for Safety Assessment using Human iPS Cells Reviewed

    Takafumi Shirakawa, Ikuro Suzuki

    Current Pharmaceutical Biotechnology   21 ( 9 )   780 - 786   2020.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Bentham Science Publishers Ltd.  

    Neurotoxicity, as well as cardiotoxicity and hepatotoxicity, resulting from administration of a test article is considered a major adverse effect both pre-clinically and clinically. Among the different types of neurotoxicity occurring during the drug development process, seizure is one of the most serious one. Seizure occurrence is usually assessed using in vivo animal models, the Functional Observational Battery, the Irwin test or electroencephalograms. In in vitro studies, a number of assessments can be performed using animal organs/cells. Interestingly, recent developments in stem cell biology, especially the development of Human-Induced Pluripotent Stem (iPS) cells, are enabling the assessment of neurotoxicity in human iPS cell-derived neurons. Further, a Multi-Electrode Array (MEA) using rodent neurons is a useful tool for identifying seizure-inducing compounds. The Consortium for Safety Assessment using Human iPS Cells (CSAHi; http://csahi.org/en/) was established in 2013 by the Japan Pharmaceutical Manufacturers Association (JPMA) to verify the application of human iPS cell-derived neuronal cells to drug safety evaluation. The Neuro Team of CSAHi has been attempting to evaluate the seizure risk of compounds using the MEA platform. Here, we review the current status of neurotoxicity and recent work, including problems related to the use of the MEA assay with human iPS neuronal cell-derived neurons, and future developments.

    DOI: 10.2174/1389201020666191129103730

    researchmap

  • Impact of Sleep–Wake-Associated Neuromodulators and Repetitive Low-Frequency Stimulation on Human iPSC-Derived Neurons Reviewed

    Remi Yokoi, Miho Okabe, Naoki Matsuda, Aoi Odawara, Akihiro Karashima, Ikuro Suzuki

    Frontiers in Neuroscience   13   2019.5

     More details

    Authorship:Last author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Frontiers Media SA  

    DOI: 10.3389/fnins.2019.00554

    researchmap

  • Synchronous spike patterns in differently mixed cultures of human iPSC-derived glutamatergic and GABAergic neurons Reviewed

    Takuya Sasaki, Ikuro Suzuki, Remi Yokoi, Kaoru Sato, Yuji Ikegaya

    Biochemical and Biophysical Research Communications   513 ( 2 )   300 - 305   2019.5

     More details

    Authorship:Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2019.03.161

    researchmap

  • Neuroprotective efficacy of thymoquinone against amyloid beta-induced neurotoxicity in human induced pluripotent stem cell-derived cholinergic neurons

    A.H. Alhibshi, A. Odawara, I. Suzuki

    Biochemistry and Biophysics Reports   17   122 - 126   2019.3

     More details

    Authorship:Last author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrep.2018.12.005

    researchmap

  • Toxicological evaluation of convulsant and anticonvulsant drugs in human induced pluripotent stem cell-derived cortical neuronal networks using an MEA system Reviewed

    A. Odawara, N. Matsuda, Y. Ishibashi, R. Yokoi, I. Suzuki

    Scientific Reports   8 ( 1 )   2018.7

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Functional evaluation assays using human induced pluripotent stem cell (hiPSC)-derived neurons can predict the convulsion toxicity of new drugs and the neurological effects of antiepileptic drugs. However, differences in responsiveness depending on convulsant type and antiepileptic drugs, and an evaluation index capable of comparingin vitroresponses within vivoresponses are not well known. We observed the difference in synchronized burst patterns in the epileptiform activities induced by pentylentetrazole (PTZ) and 4-aminopryridine (4-AP) with different action mechanisms using multi-electrode arrays (MEAs); we also observed that 100 µM of the antiepileptic drug phenytoin suppressed epileptiform activities induced by PTZ, but increased those induced by 4-AP. To comparein vitroresults within vivoconvulsive responses, frequency analysis of below 250 Hz, excluding the spike component, was performed. Thein vivoconvulsive firing enhancement of the high γ wave and β wave component were observed remarkably inin vitrohiPSC-derived neurons with astrocytes in co-culture. MEA measurement of hiPSC-derived neurons in co-culture with astrocytes and our analysis methods, including frequency analysis, appear effective for predicting convulsion toxicity, side effects, and their mechanism of action as well as the comparison of convulsions inducedin vivo.

    DOI: 10.1038/s41598-018-28835-7

    researchmap

    Other Link: https://www.nature.com/articles/s41598-018-28835-7

  • Detection of synchronized burst firing in cultured human induced pluripotent stem cell-derived neurons using a 4-step method Reviewed

    N. Matsuda, A. Odawara, H. Katoh, N. Okuyama, R. Yokoi, I. Suzuki

    Biochemical and Biophysical Research Communications   497 ( 2 )   612 - 618   2018.3

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2018.02.117

    researchmap

  • Temporally coordinated spiking activity of human induced pluripotent stem cell-derived neurons co-cultured with astrocytes Reviewed

    Tasuku Kayama, Ikuro Suzuki, Aoi Odawara, Takuya Sasaki, Yuji Ikegaya

    Biochemical and Biophysical Research Communications   495 ( 1 )   1028 - 1033   2018.1

     More details

    Authorship:Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2017.11.115

    researchmap

  • Bundle Gel Fibers with a Tunable Microenvironment for in Vitro Neuron Cell Guiding Reviewed

    Sayaka Tachizawa, Haruko Takahashi, Young-Jin Kim, Aoi Odawara, Joris Pauty, Yoshiho Ikeuchi, Ikuro Suzuki, Akihiko Kikuchi, Yukiko T. Matsunaga

    ACS Applied Materials &amp; Interfaces   9 ( 49 )   43250 - 43257   2017.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/acsami.7b14585

    researchmap

  • ヒトiPS細胞由来神経ネットワークの電気活動計測に最適なCNT-Pt/pt-blackハイブリッド平面微小電極アレイチップの開発

    鈴木郁郎

    材料の科学と工学   54(1) 14-17   2017.2

     More details

    Language:Japanese  

    researchmap

  • ヒト由来神経細胞の新規薬効評価系を目指したオンチップニューロシナプス機能計測技術の開発

    鈴木郁郎

    vol.30-2 p33-39   2017.1

     More details

    Language:Japanese  

    researchmap

  • 神経伝達物質の超高感度リアルタイム検出を目指したカーボンナノチューブ微小電極アレイの創製

    鈴木郁郎

    第30集 p.46-50   2017.1

     More details

    Language:Japanese  

    researchmap

  • Near–Infrared‐Responsive Peptide that Targets Collagen Fibrils to Induce Cytotoxicity

    Masayuki Honda, Aoi Odawara, Ikuro Suzuki, Morio Shimada, Kohki Yoshikawa, Tomoko Okada

    Photochemistry and Photobiology   92 ( 5 )   767 - 770   2016.8

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    A novel conjugate, PHG 10 dye, was synthesized using a collagen peptide and a near–infrared ( NIR )‐responsive dye to achieve targeted cytotoxicity. The collagen peptide motif, ‐(Pro‐Hyp‐Gly) <sub>10</sub> ‐ ( PHG 10), was incorporated for targeting collagen fibrils that are excessively produced by activated fibroblasts around tumor cells. PHG 10 dye was purified by HPLC and identified by MALDI ‐ MS . The phototoxicity and cytotoxicity of PHG 10 dye were examined using human glioma cells ( HGC s). Fluorescent images indicated that PHG 10 dye preferably assembled to collagen‐coated HGC s compared with noncoated HGC s. Under irradiation with NIR light, effective cytotoxicity was observed on collagen‐coated HGC s within 20 min. Because phototoxicity and cytotoxicity are dependent on the assembled amount of PHG 10 dye, the targeting of collagen fibrils by the collagen peptide motif PHG 10 is assured.

    DOI: 10.1111/php.12621

    researchmap

  • Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture

    A. Odawara, H. Katoh, N. Matsuda, I. Suzuki

    Scientific Reports   6 ( 1 )   2016.5

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    The functional network of human induced pluripotent stem cell (hiPSC)-derived neurons is a potentially powerfulin vitromodel for evaluating disease mechanisms and drug responses. However, the culture time required for the full functional maturation of individual neurons and networks is uncertain. We investigated the development of spontaneous electrophysiological activity and pharmacological responses for over 1 year in culture using multi-electrode arrays (MEAs). The complete maturation of spontaneous firing, evoked responses, and modulation of activity by glutamatergic and GABAergic receptor antagonists/agonists required 20–30 weeks. At this stage, neural networks also demonstrated epileptiform synchronized burst firing (SBF) in response to pro-convulsants and SBF suppression using clinical anti-epilepsy drugs. Our results reveal the feasibility of long-term MEA measurements from hiPSC-derived neuronal networksin vitrofor mechanistic analyses and drug screening. However, developmental changes in electrophysiological and pharmacological properties indicate the necessity for the international standardization of culture and evaluation procedures.

    DOI: 10.1038/srep26181

    researchmap

    Other Link: https://www.nature.com/articles/srep26181

  • ナノエレクトロニクス技術と神経3次元培養技術を駆使したニューロシナプス機能の非侵襲リアルタイム計測技術の開発

    鈴木郁郎

    第46集   2016.3

     More details

    Authorship:Lead author, Last author   Language:Japanese  

    researchmap

  • Induction of long-term potentiation and depression phenomena in human induced pluripotent stem cell-derived cortical neurons

    A. Odawara, H. Katoh, N. Matsuda, I. Suzuki

    Biochemical and Biophysical Research Communications   469 ( 4 )   856 - 862   2016.1

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2015.12.087

    researchmap

  • 平面微小電極アレイチップの作製と構造解析

    鈴木郁郎

    平成26年度成果報告書 pp.121 197   2015.12

     More details

    Language:Japanese  

    researchmap

  • ヒトiPS細胞由来ニューロンのエレクトロセンシング技術の開発

    鈴木郁郎

    第24号 成果集 pp.82-85   2015.9

     More details

    Language:Japanese  

    researchmap

  • Development of Interdigitated Carbon Nanotube Electrode Using Electro-plating and High sensitive Neurotransmitter Sensing

    I. Suzuki

    No.26 516-522   2014.12

     More details

    Language:Japanese  

    researchmap

  • Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage

    A.H. Alhebshi, A. Odawara, M. Gotoh, I. Suzuki

    Neuroscience Letters   570   126 - 131   2014.6

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.neulet.2013.09.049

    researchmap

  • Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture

    A. Odawara, Y. Saitoh, A.H. Alhebshi, M. Gotoh, I. Suzuki

    Biochemical and Biophysical Research Communications   443 ( 4 )   1176 - 1181   2014.1

     More details

    Authorship:Last author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2013.12.142

    researchmap

  • Carbon nanotube multi-electrode array chips for noninvasive real-time measurement of dopamine, action potentials, and postsynaptic potentials Reviewed

    Ikuro Suzuki, Mao Fukuda, Keiichi Shirakawa, Hideyasu Jiko, Masao Gotoh

    Biosensors and Bioelectronics   49   270 - 275   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bios.2013.05.023

    researchmap

  • Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity Reviewed

    A.H. Alhebshi, M. Gotoh, I. Suzuki

    Biochemical and Biophysical Research Communications   433 ( 4 )   362 - 367   2013.4

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.bbrc.2012.11.139

    researchmap

  • A Simplified Micropatterning Method for Straight-line Neurite Extension of Cultured Hippocampal Neurons Reviewed

    Ikuro Suzuki, Kosuke Nakamura, Aoi Odawara, Amani Alhebshi, Masao Gotoh

    Analytical Sciences   29 ( 2 )   263 - 266   2013.2

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.2116/analsci.29.263

    researchmap

    Other Link: https://link.springer.com/article/10.2116/analsci.29.263/fulltext.html

  • Development of three-dimensional neuronal culture technique using a radial glia-like neural stem cell line Reviewed

    K. Ono, I. Suzuki, A. Odawara, M. Sato, T. Ikegaya, A. Gotoh

    Journal of Bioscience and Bioengineering   116 ( 5 )   575 - 581   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Control of neural network patterning using collagen gel photothermal etching Reviewed

    Aoi Odawara, Masao Gotoh, Ikuro Suzuki

    Lab on a Chip   13 ( 11 )   2040 - 2040   2013

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

    DOI: 10.1039/c3lc00036b

    researchmap

  • Carbon nanotube multi-electrode array chips for noninvasive real-time measurement of dopamine, action potentials, and postsynaptic potentials Reviewed

    Y. Matsui, T. Yokoyama, A. Suzumura, M. Yoshida, D. Kino-oka, I. Suzuki, T. Kotani, S. Takeuchi, M. Nakanishi, S. Nakanishi

    Advanced Healthcare Materials   2 ( 1 )   144 - 148   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • High Sensitive Electrochemical Measurements of Neurotransmitters Using Multi-Wall Carbon Nano-Tube Electrodes Reviewed

    Ikuro Suzuki, Mao Fukuda, Shota Amano, Masao Gotoh

    IEEJ Transactions on Electronics, Information and Systems   133 ( 11 )   2068 - 2074   2013

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Institute of Electrical Engineers of Japan (IEE Japan)  

    DOI: 10.1541/ieejeiss.133.2068

    researchmap

  • Microcontact printing-based reconstruction and electrophysiological characterization of neuronal networks in vitro Reviewed

    A. Odawara, A. Gotoh, I. Suzuki

    Journal of Neuroscience Methods   217 ( 119 )   2013

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • A three-dimensional neuronal culture technique that controls the direction of neurite elongation and the position of soma to mimic the layered structure of the brain Reviewed

    Aoi Odawara, Masao Gotoh, Ikuro Suzuki

    RSC Advances   3 ( 45 )   23620 - 23620   2013

     More details

    Authorship:Last author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

    DOI: 10.1039/c3ra44757j

    researchmap

  • High Sensitive Electrochemical Measurements of Dopamine Using Carbon Nanotube Multi-Electrode Arrays Reviewed

    M. Nakanishi, D. Kino-oka, Y. Matsui, T. Yokoyama, I. Suzuki, T. Kotani, S. Nakanishi

    IEEJ Transactions on Electronics, Information and Systems   133 ( 8 )   1479 - 1484   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • A simple method for the micropatterning of glial cells and its application to the reconstruction of neuronal network Reviewed

    A. Odawara, A. Gotoh, I. Suzuki

    Brain Research Bulletin   96   71 - 78   2013

     More details

    Authorship:Last author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Constructive formation and connection of aligned micrometer-scale cardiomyocyte networks for on-chip single-cell network assay Reviewed

    Y. Kaneko, A. Kojima, I. Suzuki, K. Yasuda

    The Journal of Nanobiotechnology   5   4   2007

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • マイクロウェル構造を用いたMEG細胞間相互作用の解析 Reviewed

    鈴木郁郎, 安田賢二

    電気学会論文誌C   127 ( 9 )   1459 - 1464   2007

     More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    researchmap

  • On-chip multi channel action potential recording from the cultured hippocampal slices Reviewed

    I. Suzuki, T. Sugio, A. Jimbo, K. Yasuda

    The Journal of Robotics and Mechatronics   19 ( 4 )   413 - 417   2007

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Detection of tetanus-induced effects on network activity using a 64-channel multi-electrode array Reviewed

    I. Suzuki, T. Sugio, A. Jimbo, K. Yasuda

    Journal of Neuroscience Methods   159 ( 2 )   173 - 180   2007

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Stepwise pattern modification of neuronal network in photo-thermally-etched agarose architecture on multi-electrode array chip for individual-cell-based electrophysiological measurement Reviewed

    Ikurou Suzuki, Yoshihiro Sugio, Yasuhiko Jimbo, Kenji Yasuda

    Lab on a Chip   5 ( 3 )   241 - 241   2005

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Royal Society of Chemistry (RSC)  

    DOI: 10.1039/b406885h

    researchmap

  • Modification of a neuronal network direction using stepwise photo-thermal etching of an agarose architecture Reviewed

    Ikurou Suzuki, Yoshihiro Sugio, Hiroyuki Moriguchi, Yasuhiko Jimbo, Kenji Yasuda

    Journal of Nanobiotechnology   2 ( 1 )   7   2004.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1186/1477-3155-2-7

    researchmap

  • Individual-cell-based electrophysiological measurement of a topographically controlled neuronal network pattern using agarose architecture with a multi-electrode array Reviewed

    I. Suzuki, T. Sugio, A. Jimbo, K. Yasuda

    Japanese Journal of Applied Physics   43 ( 6B )   4037 - 4041   2004

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Pattern modification of neuronal network in photo-thermally-etched agarose architecture on multi-electrode array chip Reviewed

    I. Suzuki, T. Sugio, A. Jimbo, K. Yasuda

    International Journal of Bioelectromagnetism   6 ( 1 )   2004

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

  • Non-destructive on-chip cell sorting system with real-time microscopic image processing Reviewed

    I. Suzuki, Y. Sugai, M. Hattori, T. Kobayashi, K. Yasuda

    Japanese Journal of Applied Physics   43 ( 6B )   4042 - 4045   2004

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    researchmap

▼display all

Books

  • 培養細胞が拓く創薬の今 : 研究、規制、自動化、そして教育へ = Cell culture leading the way to drug discovery : research,regulations,automation,and beyond

    古江‐楠田, 美保( Role: Contributor第5編 MEA, 第一章 in vitro神経ネットワークにおけるMEA研究)

    シーエムシー・リサーチ  2025.3  ( ISBN:9784910581644 )

     More details

    Total pages:xv, 373p   Language:Japanese  

    CiNii Research

    researchmap

  • 日本薬理学雑誌

    鈴木郁郎( Role: Sole author第160巻第2号、特集「拡がるMicrophysiological systems(MPS)の利活用―創薬応用に向けた新展開―」中「神経MPSの可能性」pp.92-96)

    2025 

     More details

  • オルガノイド研究 ~培養・作製、活用、臨床応用~

    鈴木郁郎( Role: Contributor第2章 分析・解析手法の開発 第2節「ヒト脳オルガノイドの電気活動計測と化合物応答」)

    エヌ・ティー・エス  2024 

     More details

  • 毒性学コミュニケーション/毒性学トピックス解説

    鈴木郁郎( Role: Sole author「New approach methodsを用いた発達神経毒性アッセイの国際動向」)

    一般社団法人日本毒性学会  2024 

     More details

  • Cell Processing Technology

    Ikuro Suzuki( Role: ContributorToxicological Assessment of Drugs Based on Electrical Activities of Human iPSC-Derived Cortical Neurons, Sensory Neurons and Cerebral Organoids)

    Springer Singapore  2024 

     More details

  • 動物実験代替法とNew approach methodologiesの開発・利用動向

    鈴木郁郎( Role: Contributor第IV編 農薬業界 第4章「発達神経毒性評価」)

    シーエムシー出版  2023.9  ( ISBN:9784781317472 )

     More details

    Total pages:x, 296p   Language:Japanese  

    CiNii Research

    researchmap

  • ペランパネルによるてんかん治療のストラテジー 第2版

    鈴木郁郎( Role: ContributorPart 1 分子病態から探るてんかん原性メカニズム「脳オルガノイドを用いたてんかん原性研究」)

    2022.9 

     More details

  • 谷本学校 毒性質問箱

    鈴木郁郎( Role: Sole author第24号「ヒトiPS神経の電気活動に基づいた化合物の毒性及び作用機序予測」pp.20-31)

    2022 

     More details

  • 日本薬理学会誌

    鈴木郁郎( Role: Sole author第155巻第5号「ヒトiPS神経の機能を指標とした医薬品の神経毒性予測および薬効評価への取り組み」pp.289-294)

    2020 

     More details

  • 日本薬理学会誌

    白川誉史, 鈴木郁郎( Role: Joint author第155巻第5号「ヒトiPS細胞由来神経細胞を用いた痙攣評価系の検討」pp.284-288)

    2020 

     More details

  • 医薬品開発における創薬スクリーニング関連技術開発

    鈴木郁郎( Role: Contributor第5章第3節「MEA計測機器を利用した安全性評価・創薬スクリーニング」)

    2019.12 

     More details

  • 脱細胞化組織の作製法と医療・バイオ応用

    鈴木郁郎, 木村剛( Role: Contributor第III編 第9章「脱細胞化脳」)

    シーエムシー出版  2019 

     More details

  • 創薬のための細胞利用技術の最新動向と市場

    鈴木郁郎( Role: Contributor第II編 創薬・新薬への応用 第2章 薬剤安全性評価への応用「ヒトiPS細胞由来神経細胞の機能評価と創薬応用」)

    シーエムシー・リサーチ  2018 

     More details

  • iPS細胞の最新技術開発

    鈴木郁郎( Role: Contributor3章 iPS細胞を用いた医薬品の安全性・有効性評価技術 6節「iPS細胞を用いたニューロンの作製と薬効評価技術」pp.139-148)

    技術情報協会  2016 

     More details

  • 細胞の特性計測・操作と応用(細胞工学ライブラリーマイクロロボティクスとバイオの融合-1)

    鈴木郁郎( Role: Contributor第3章 細胞分離への応用「マイクロ流体チップを用いた細胞カプセルの分離」pp.213-224)

    コロナ社  2016 

     More details

  • 電気工学ハンドブック(第7版)

    鈴木郁郎( Role: Contributor2編 基礎物理 11章「生体電磁気現象」pp.37-39)

    電気学会出版会  2013 

     More details

▼display all

MISC

  • Dynamics of Long-Term Activities in Single Neuronal Cell

    SUZUKI Ikurou

    Seibutsu Butsuri   49 ( 6 )   304 - 305   2009

     More details

    Language:Japanese   Publisher:The Biophysical Society of Japan General Incorporated Association  

    DOI: 10.2142/biophys.49.304

    CiNii Research

    researchmap

  • Chaotropic etching for fabricating microwells for cell culture

    Nobuhiro Tamai, Hiroyuki Moriguchi, Yuzo Takayama, Yasuhiko Jimbo, Ikuro Suzuki, Kenji Yasuda

    IEEJ Transactions on Electronics, Information and Systems   127 ( 10 )   12 - 1574   2007

     More details

    Language:English   Publisher:Institute of Electrical Engineers of Japan  

    DOI: 10.1541/ieejeiss.127.1568

    Scopus

    researchmap

  • シンプルな神経回路の電気活動計測

    玉井暢洋, 高山祐三, 森本晃司, 倉島利明, 尾崎友彦, 鈴木郁郎, 安田賢二, 小林英津子, 佐久間一郎, 神保泰彦

    日本生体医工学会大会プログラム・論文集   45th   475   2006.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • マイクロパターニングを利用した培養神経回路の細胞内Caダイナミクスの計測

    高山祐三, 玉井暢洋, 森本晃司, 倉島利明, 尾崎友彦, 鈴木郁郎, 安田賢二, 小林英津子, 佐久間一郎, 神保泰彦

    日本生体医工学会大会プログラム・論文集   45th   472   2006.5

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • Simultaneous recording of intracellular Ca dynamics and electrical activity in cultured cortical networks based on MEA technique

    TAKAYAMA YUZO, TAMAI NOBUHIRO, MORIMOTO KOJI, KURASHIMA TOSHIAKI, OZAKI TOMOHIKO, SUZUKI IKURO, YASUDA KENJI, KOBAYASHI ETSUKO, SAKUMA ICHIRO, JIMBO YASUHIKO

    電気学会医用・生体工学研究会資料   MBE-06 ( 1-22 )   5-10 - 10   2006.4

     More details

  • Formation control of cultured neuronal networks by agarose micro-patterning

    TAMAI NOBUHIRO, TAKAYAMA YUZO, MORIMOTO KOJI, SUZUKI IKURO, YASUDA KENJI, KOBAYASHI ETSUKO, SAKUMA ICHIRO, JIMBO YASUHIKO

    生体・生理工学シンポジウム論文集   20th   35-36   2005.9

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 3P307 Development of a new system for acquiring action potentials from individual neurons derived from suprachiasmatic nucleus

    Sugio Y, Terazono H, Suzuki I, Kaneko T, Nakashima M, Sasaki H, Jimbo Y, Yasuda K

    Seibutsu Butsuri   44 ( 0 )   S266 - S266   2004

     More details

    Language:Japanese   Publisher:The Biophysical Society of Japan General Incorporated Association  

    CiNii Research

    researchmap

▼display all

Presentations

  • Effects of CNN Models on Feature Extraction for Extracellular Matrix Structure Feature Map Generation

    Kazuki Hoashi, Ikuro Suzuki, Naoki Matsuda, Akio Kishida, Tsuyoshi Kimura, Motoki Takagi

    Society For Biomaterials 2025  2025.4 

     More details

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • ECM構造特徴マップを用いた脱細胞化処理のECM構造への影響の定量化

    帆足和希, 松田直毅, 鈴木郁郎, 髙木基樹, 岸田晶夫, 木村剛, 中村奈緒子

    第24回日本再生医療学会総会  2025.3 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Development of a novel in vitro neurotoxicity assay using field potential imaging and microphysiological systems on CMOS-MEA

    Ikuro Suzuki, Naoki Matsuda, Xiaobo Han, Yuto Ishibashi, Hideaki Kurashiki, Remi Yokoi

    SOT 2025  2025.3 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • In vitro developmental neurotoxicity (DNT) assays using CYTOQUBE & FDSS technologies

    Nami Nagafuku, Remi Yokoi, Naoki Matsuda, Yuto Ishibashi, Yiwen Wang, Sunao Hisada, Hirofumi Horai, Ikuro Suzuki

    SOT 2025  2025.3 

     More details

    Language:English   Presentation type:Poster presentation  

    researchmap

  • in vitroヒト神経モデルを用いた依存症等の有害事象予測と先端計測

    鈴木 郁郎

    第16回日本安全性薬理研究会学術年会  2025.2 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • in vitro神経モデルを用いた化合物評価

    鈴木 郁郎

    日本動物実験代替法学会 第37回大会  2024.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • ヒト由来神経細胞を用いたNAMsやMPSの利活用と国際動向

    鈴木 郁郎

    第47回日本分子生物学会年会  2024.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • in vitro MEA試験による化合物の神経作用評価

    鈴木 郁郎

    第41回「センサ・マイクロマシンと応用システム」シンポジウム  2024.11 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • 化合物評価におけるIVIVEへの取り組み

    鈴木郁郎

    LIFE2024  2024.9 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • ヒトiPS由来神経細胞およびアストロサイトを用いたin vitro痙攣毒性予測と作用機序予測

    鈴木郁郎

    第51回日本毒性学会学術年会  2024.7 

     More details

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • CMOS-MEAシステムおよび細胞外電位と神経伝達物質の同時計測MEAシステムによるin vitro化合物評価

    鈴木郁郎

    第97回日本薬理学会年会  2023.12 

     More details

    Event date: 2023.12

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 化合物評価におけるMEAアッセイの現状と今後

    鈴木郁郎

    Japan Spotfire User Group Meeting  2023.12 

     More details

    Event date: 2023.12

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • In vitro神経活動計測とAIによる創薬応用

    鈴木郁郎

    第44回日本薬学会 九州山口支部コロキウム  2023.10 

     More details

    Event date: 2023.10

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • MEA計測法による化合物の神経毒性評価

    鈴木郁郎

    第50回毒性学会学術年会  2023.6 

     More details

    Event date: 2023.6

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • MEAを用いた化合物の神経毒性評価法の開発

    鈴木郁郎

    電気化学会第89回大会  2022.3 

     More details

    Event date: 2022.3

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • iPSニューロンの機能を指標とした中枢および末梢神経毒性評価

    鈴木郁郎

    安全性評価研究会 第29回 夏の教育フォーラム  2021.9 

     More details

    Event date: 2021.9

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    researchmap

  • High-Precision Neurotoxicity and Neuropharmacology Assessment in CNS Models Using Field Potential Imaging

    N. Matsuda, N. Nagafuku, H. Kurashiki, B. Noda, I. Suzuki

    2026 SOT Annual Meeting and ToxExpo 

     More details

    Event date: 2026.3

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Using a Novel Microphysiologicl System on MEA to Evaluate Neuron Electrical Characteristics and Synaptic Signal Conduction for in vitro Neurological Disorder Model

    Ikuro Suzuki, Xiaobo Han, Naoki Matsuda, Remi Yokoi, Hideaki, Kurashiki, Makoto Yamanaka

    AD/PD™ 2026: Alzheimer’s Disease and Parkinson’s Disease Conference 

     More details

    Event date: 2026.3

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Neural Activity Mapping in Brain Organoids and Midbrain-Striatum Assembloids Using Ultra-High-Density CMOS-MEA

     More details

    Event date: 2026.3

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Assessment of Electrical Signal Transduction through Neural Synapse Network Using a Novel Microphysiological System on MEA

     More details

    Event date: 2026.3

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Development of a highly sensitive method for predicting cardiotoxicity in human iPSC-derived cardiomyocytes using UHD-CMOS-MEA

     More details

    Event date: 2026.3

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Development of a Cardiotoxicity Mechanism Prediction Method Based on AI Analysis of Field Potential Imaging Data from Human iPSC-Derived Cardiomyocytes

     More details

    Event date: 2026.3

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Multilevel Assessment of Neural Network Responses to Inhibitory Modulation Using an Ultra-High-Density CMOS-MEA

    Hideaki Kurashiki, Naoki Matsuda, Xiaobo Han, Ikuro Suzuki

     More details

    Event date: 2026.2

    Language:English   Presentation type:Poster presentation  

    researchmap

  • A Novel Microphysiological System (MPS) –MEA Platform for in Vitro Functional Evaluation with Compartmentalized Cultured Neural Models

    Xiaobo Han, Naoki Matsuda, Chinatsu Suzuki, Makoto Yamanaka, Bumpei Noda, Ikuro Suzuki

     More details

    Event date: 2026.2

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Detection of Chronic Cardiotoxicity Using UHD-CMOS-MEA in hiPSC-Derived Cardiomyocytes

    Naoki Matsuda, Nami Nagafuku, Ikuro Suzuki

     More details

    Event date: 2026.2

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Development of a Cardiotoxicity Mechanism Prediction, Method Based on AI Analysis of Field Potential Imaging Data from Human iPSC-Derived Cardiomyocytes

    Shuri Kikuchi, Nami Nagafuku, Naoki Matsuda, Ikuro Suzuki

     More details

    Event date: 2026.2

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 高時空間分解能CMOS-MEAを用いた単一細胞レベルの電気活動評価

    松田直毅, 永福菜美, 石橋勇人, 韓笑波, 横井れみ, 鈴木郁郎

    第1回日本疾患幹細胞学会学術集会 

     More details

    Event date: 2026.2

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • ヒトiPSC由来ニューロンのMEA計測による化合物の毒性評価

    石橋勇人, 永福菜美, 鈴木郁郎

    第1回日本疾患幹細胞学会学術集会 

     More details

    Event date: 2026.2

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • Developing compartmentalized co-culturing neural models in a novel MPS-MEA system for in vitro drug assessment

    Ikuro Suzuki, Xiaobo Han, Naoki Matsuda, Chinatsu Suzuki, Makoto Yamanaka, Kenishi Hirose, Bumpei Noda

    SLAS2026 International Conference & Exhibition 

     More details

    Event date: 2026.2

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Prediction of toxicity risk and adverse effects using MEA measurement of human iPSC-derived neurons

    Yuto Ishibashi, Nami Nagafuku, Bumpei, Noda, Ikuro Suzuki

    SLAS2026 International Conference & Exhibition 

     More details

    Event date: 2026.2

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 高時空間分解能CMOS-MEAによる電気イメージングを用いた単一細胞レベルの化合物応答評価

    松田直毅, 永福菜美, 石橋勇人, 韓笑波, 横井れみ, 鈴木郁郎

    第16回スクリーニング学研究会 

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 異種細胞間神経接続を模倣する神経MPSを搭載したMEAプラットフォームの開発

    山中誠, 韓笑波, 鈴木郁郎

    第16回スクリーニング学研究会 

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • ヒトiPSC由来ニューロンのMEAデータを用いた毒性・副作用リスク推定

    石橋勇人, 永福菜美, 鈴木郁郎

    第16回スクリーニング学研究会 

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • ヒト細胞電気活動で切り開く創薬・リスク評価、そして脳理解

    鈴木郁郎

    東北医科薬科大学×東北工業大学医薬工研究連携キックオフセミナー 

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • High-resolution mapping of beta rhythm induction in acute brain slices using field potential imaging with ultra-high-density CMOS-MEA

    N. MATSUDA, B. NODA, I. SUZUKI

    Neuroscience 2025 

     More details

    Event date: 2025.11

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Precision neural activity mapping in brain organoids through field potential imaging with ultra-high-density CMOS microelectrode array

    R. YOKOI, N. MATSUDA, Y. ISHIBASHI, B. NODA, I. SUZUKI

    Neuroscience 2025 

     More details

    Event date: 2025.11

    Language:English   Presentation type:Poster presentation  

    researchmap

  • A microphysiological system on ultra-high-density CMOS-MEA for in vitro functional evaluation with compartmentalized co-culturing neural models

    X. HAN, N. MATSUDA, M. YAMANAKA, B. NODA, I. SUZUKI

    Neuroscience 2025 

     More details

    Event date: 2025.11

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 23.7万電極による高密度MEA:細胞電気活動の高精度マッピング

    鈴木郁郎

    バイオインダストリー協会”未来へのバイオ技術”勉強会 

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • ヒトiPSニューロンとマルチスケールMEAプラットフォームを用いた化合物の神経安全性評価

    鈴木郁郎

    日本動物実験代替法学会 第38回大会 

     More details

    Event date: 2025.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Development of an evaluation method for addictive compounds based on electrical activity of human iPS cell-derived dopaminergic neurons using MEA, 2025 SPS Annual Meeting

    Y Ishibashi, N Nagafuku, B Noda, I Suzuki

    2025 SPS Annual Meeting 

     More details

    Event date: 2025.10

    Language:English   Presentation type:Poster presentation  

    researchmap

  • Prediction of toxicity risk and symptom-specific adverse effects using MEA measurements of human iPSC-derived neurons

    Y Ishibashi, N Nagafuku, B Noda, I Suzuki

    2025 SPS Annual Meeting 

     More details

    Event date: 2025.10

    Language:English   Presentation type:Poster presentation  

    researchmap

  • High-Resolution In Vitro Electrophysiological Profiling of Drug-Induced Cardiotoxicity Using UHD-CMOS-MEA in Human iPSC-Derived Cardiomyocytes

    N Matsuda, N Nagafuku, B Noda, I Suzuki

    2025 SPS Annual Meeting 

     More details

    Event date: 2025.10

    Language:English   Presentation type:Poster presentation  

    researchmap

  • 神経MEAアッセイを活用した化合物毒性評価と国際動向

    鈴木郁郎

    第15回レギュラトリ―サイエンス学会学術大会 

     More details

    Event date: 2025.9

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • 細胞の電気を読むAI:創薬のブレークスルーへ

    鈴木郁郎

    東北SDGs研究実施拠点 産学連携交流会 

     More details

    Event date: 2025.8

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • Electrophysiological profiling or cardiotoxicity risk prediction using UHD-CMOS-MEA in human iPSC-derived cardiomyocytes

    Ikuro Suzuki

    MEA meeting 2025 

     More details

    Event date: 2025.7

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • A novel in vitro neurotoxicity assay using field potential imaging on Ultra HD-CMOS-MEA

    Ikuro Suzuki, Naoki Matsuda, Xiaobo Han, Yuto Ishibashi, Hideaki Kurashiki, Remi Yokoi

    MEA meeting 2025 

     More details

    Event date: 2025.7

    Language:English   Presentation type:Poster presentation  

    researchmap

  • in vitro先端計測技術と解析技術を用いた神経・心臓における化合物安全性評価法

    鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • UHD-CMOS-MEAを用いた脳オルガノイドおよび中脳-線条体アセンブロイドの機能解析

    横井れみ, 松田直毅, 石橋勇人, 鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • in vitro先端計測技術と解析技術を用いた神経・心臓における化合物安全性評価

    鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Oral presentation (general)  

    researchmap

  • MPS-MEAシステムで培養したヒトiPSC由来ニューロンを用いた末梢神経障害評価系の新規開発

    韓笑波, 松田直毅, 鈴木智夏, 山中誠, 鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • UHD-CMOS-MEA計測による高感度な心毒性検出と作用機序予測法の開発

    永福菜美, 松田直毅, 石橋勇人, 鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 機械学習を用いたヒトiPS細胞由来ニューロンのMEA測定による神経毒性評価法の開発

    松田直毅, 永福菜美, 石橋勇人, 鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 高密度CMOS-MEAによるラット海馬培養系の神経毒性誘発機能障害の解析

    倉敷秀明, 韓笑波, 松田直毅, 鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • 100化合物に対するヒトiPSC由来ニューロンのMEAデータを用いた神経毒性予測と副作用リスク推定

    石橋勇人, 永福菜美, 鈴木郁郎

    第52回日本毒性学会学術年会 

     More details

    Event date: 2025.7

    Language:Japanese   Presentation type:Poster presentation  

    researchmap

  • DEVELOPMENT OF AN HD-CMOS-MEA-BASED METHOD FOR CARDIOTOXICITY DETECTION AND MECHANISM-OF-ACTION PREDICTION IN HUMAN IPSC-DERIVED CARDIOMYOCYTES USING BEAT PROPAGATION PATTERNS

    Naoki Matsuda, Nami Nagafuku, Bumpei Noda, Ikuro Suzuki

    ISSCR 2025 Annual Meeting 

     More details

    Event date: 2025.6

    Language:English   Presentation type:Poster presentation  

    researchmap

  • A Characteristics of Electrical Activities at Single-cell Resolution on hiPSC-derived Neurons with a Novel Field Potential Imaging Method on HD-CMOS-MEA

    Ikuro Suzuki, Remi Yokoi, Xiaobo Han, Nami Nagafuku, Hideaki Kurashiki, Chinatsu Suzuki, Yuto Ishibashi, Naoki Matsuda

    ISSCR 2025 Annual Meeting 

     More details

    Event date: 2025.6

    Language:English   Presentation type:Poster presentation  

    researchmap

  • A Novel in vitro Microphysiological System Culturing Different Types of hiPSC-derived Peripheral Neurons on MEA for Neuropathy Assessment

    Xiaobo Han, Naoki Matsuda, Chinatsu Suzuki, Makoto Yamanaka, Ikuro Suzuki

    ISSCR 2025 Annual Meeting 

     More details

    Event date: 2025.6

    Language:English   Presentation type:Poster presentation  

    researchmap

▼display all

Industrial property rights

  • 解析システム

    鈴木郁郎, 松田直毅, 山中誠

     More details

    Application no:特願2026-010587  Date applied:2026

    researchmap

  • 神経興奮作用抑制剤

    鈴木郁郎, 松田直毅, 石橋勇人, 好田裕史, 中原光一, 前川知浩

     More details

    Applicant:サントリーホールディングス株式会社, 学校法人東北工業大学

    Application no:特願2022-209650  Date applied:2022.12

    Announcement no:特開2024-093340  Date announced:2024.7

    researchmap

  • 神経細胞デバイス、その製造方法、及び神経活動評価方法

    須藤正樹, 遠井紀江, 鈴木郁郎

     More details

    Applicant:学校法人東北工業大学, 株式会社幹細胞&デバイス研究所

    Application no:特願2022-024849  Date applied:2022.2

    Announcement no:特開2022-135969  Date announced:2022.9

    researchmap

  • マイクロ流体デバイス及びマイクロ流体デバイスの使用方法

    鈴木郁郎, 山中誠

     More details

    Applicant:ソニーセミコンダクタソリューションズ株式会社

    Application no:特願2022-176317  Date applied:2022

    researchmap

  • 脳から取得される波形データに対してバースト解析を行う方法、コンピュータシステム、プログラム、ならびに、バースト解析を用いて標的の状態を予測する方法、コンピュータシステム、プログラム

    鈴木郁郎, 石橋勇人

     More details

    Applicant:学校法人東北工業大学

    Application no:特願2022-500622  Date applied:2021.7

    Announcement no:特開JPWO2022-034802  Date announced:2022.2

    Patent/Registration no:特許第7138995号  Date registered:2022.9  Date issued:2022.9

    Rights holder:学校法人東北工業大学

    researchmap

  • 薬剤の影響予測システム

    鈴木郁郎, 山中誠

     More details

    Applicant:ウシオ電機株式会社, 学校法人東北工業大学

    Application no:特願2021-107213  Date applied:2021.6

    Announcement no:特開特開2023-005361  Date announced:2023.1

    researchmap

  • Drug effect prediction system

    Ikuro Suzuki, Makoto Yamanaka

     More details

    Applicant:Ushio Inc., Tohoku Institute of Technology

    Application no:特願2021-107213  Date applied:2021.6

    Announcement no:特開2023-005361  Date announced:2023.1

    Patent/Registration no:特許第7762374号  Date registered:2025.10  Date issued:2025.10

    Rights holder:Ushio Inc., Tohoku Institute of Technology

    researchmap

  • マイクロ流体デバイス、マイクロ流体デバイスの製造方法、及びマイクロ流体デバイスの使用方法

    鈴木郁郎, 山中誠

     More details

    Applicant:ウシオ電機株式会社, 学校法人東北工業大学

    Application no:特願2021-097200  Date applied:2021.6

    Announcement no:特開2022-188912  Date announced:2022.12

    researchmap

  • Microfluidic device, method for manufacturing microfluidic device, and method for using microfluidic device

    Ikuro Suzuki, Makoto Yamanaka

     More details

    Applicant:Ushio Inc., Tohoku Institute of Technology

    Application no:特願特願2021-097200  Date applied:2021.6

    Announcement no:特開特開2022-188912  Date announced:2022.12

    researchmap

  • ハイドロゲル構造体の製造方法並びにそのハイドロゲル構造体を利用した生物試料の培養方法及び分析方法

    鈴木郁郎

     More details

    Applicant:学校法人東北工業大学

    Application no:特願2019-144190  Date applied:2019.8

    Announcement no:特開2021-023215  Date announced:2021.2

    Patent/Registration no:特許第7430895号  Date registered:2024.2  Date issued:2024.2

    Rights holder:学校法人東北工業大学

    researchmap

  • 計測方法

    鈴木郁郎, 小田原あおい, 饗庭一博, 遠井紀江

     More details

    Applicant:学校法人東北工業大学, 株式会社幹細胞&デバイス研究所

    Application no:特願2020-530255  Date applied:2019.7

    Announcement no:特開WO2020/013270  Date announced:2021.8

    Patent/Registration no:特許第7374422号  Date registered:2023.11  Date issued:2023.11

    Rights holder:学校法人東北工業大学、株式会社幹細胞&デバイス研究所

    researchmap

  • 神経細胞の機能的成熟化法

    鈴木郁郎, 小田原あおい, 饗庭一博, 遠井紀江

     More details

    Applicant:学校法人東北工業大学, 株式会社幹細胞&デバイス研究所

    Application no:特願JP2019/027476  Date applied:2019.7

    Announcement no:特開WO2020/013269  Date announced:2020.1

    researchmap

  • 細胞保持容器および計測システム

    鈴木郁郎, 松田直毅, 中島駿, 水野芳樹

     More details

    Applicant:株式会社SCREENホールディングス, 学校法人東北工業大学

    Application no:特願2019-052716  Date applied:2019.3

    Announcement no:特開2020-150854  Date announced:2020.9

    researchmap

  • 細胞保持容器および計測システム

    鈴木郁郎, 松田直毅, 中島駿, 水野芳樹

     More details

    Applicant:株式会社SCREENホールディングス, 学校法人東北工業大学

    Application no:特願2019-052714  Date applied:2019.3

    Announcement no:特開2020-150852  Date announced:2020.9

    researchmap

  • 計測システム

    鈴木郁郎, 松田直毅, 中島駿, 水野芳樹

     More details

    Applicant:株式会社SCREENホールディングス, 学校法人東北工業大学

    Application no:特願2019-052715  Date applied:2019.3

    Announcement no:特開2020-150853  Date announced:2020.9

    researchmap

  • 対象化合物の特性の予測を行うための方法、コンピュータシステム、プログラム

    鈴木郁郎, 松田直毅

     More details

    Applicant:学校法人東北工業大学

    Application no:特願2018-183378  Date applied:2018.9

    Announcement no:特開2020-052865  Date announced:2020.4

    Patent/Registration no:特許第6567153号  Date registered:2019.8 

    Rights holder:学校法人東北工業大学

    researchmap

  • 標的の特性の予測を行うための方法、コンピュータシステム、プログラム

    鈴木郁郎, 石橋勇人

     More details

    Applicant:学校法人東北工業大学

    Application no:特願2018-183381  Date applied:2018.9

    Announcement no:特開2020-051968  Date announced:2020.4

    Patent/Registration no:特許第6558786号  Date registered:2019.7 

    Rights holder:学校法人東北工業大学

    researchmap

  • センサー用電極およびその製造方法

    鈴木郁郎, 後藤正男

     More details

    Application no:特願2013-090405  Date applied:2013

    researchmap

  • 神経細胞とグリア細胞の細胞識別方法

    鈴木郁郎, 寺薗英之, 安田賢二, 福島守

     More details

    Applicant:オンチップ・バイオテクノロジーズ株式会社

    Application no:特願2007-125374  Date applied:2007.5

    Announcement no:特開2008-278789  Date announced:2008.11

    researchmap

  • 細胞応答計測装置および細胞応答計測チップ

    安田賢二, 鈴木郁郎, 寺薗英之, 金子智行, 服部明弘, 福島守

     More details

    Applicant:国立大学法人東京医科歯科大学

    Application no:特願2007-111322  Date applied:2007.4

    Announcement no:特開2008-263858  Date announced:2008.11

    researchmap

  • ヒストグラム画像を作成する方法、コンピュータシステム、プログラム、ならびに、ヒストグラム画像を用いて対象の状態を予測する方法、コンピュータシステム

    鈴木郁郎, 松田直毅

     More details

    Applicant:学校法人東北工業大学

    Patent/Registration no:特許第7099777号  Date registered:2022.7  Date issued:2022.7

    Rights holder:学校法人東北工業大学

    researchmap

▼display all

Awards

  • 優秀ポスター賞

    2022.11   日本薬理学会   ヒトiPS細胞由来ドーパミンニューロンの電気活動に基づく依存症誘発薬の評価

    石橋 勇人、永福 菜美、鈴木 郁郎

     More details

  • 優秀ポスター賞

    2022.11   スクリーニング学研究会   in vitro 神経活動に基づいた化学物質の神経毒性評価

    石橋 勇人、永福 菜美、鈴木 郁郎

     More details

  • 優秀ポスター賞

    2022.11   日本薬理学会   ヒトiPS細胞由来ドーパミンニューロンの電気活動に基づく依存症誘発薬の評価

    石橋 勇人, 永福 菜美, 鈴木 郁郎

     More details

  • 優秀ポスター賞

    2022.11   日本薬理学会   CMOS-MEAを用いた一細胞レベルでの末梢神経痛みのin vitro評価

    韓 笑波、柴田 実可子、松田 直毅、鈴木 郁郎

     More details

  • JSPS優秀研究発表賞

    2022.3   日本安全性薬理研究会   iPS細胞由来ドーパミンニューロンおよびマウス脳スライスを用いた依存症評価法の開発

    木村 新伍、加藤 祐理、石橋 勇人、松田 直毅、鈴木 郁郎

     More details

  • 優秀研究発表賞

    2021.2   日本安全性薬理研究会   ラット脳波を用いた薬剤性痙攣リスクを検出する新規解析方法

    石橋勇人、木下健一、岡村愛、白川誉史、鈴木郁郎

     More details

  • Poster Highlight prize

    2021.2   THE EUROPEAN LABORATORY RESEARCH & INNOVATION GROUP   Comparison of 3D versus 2D neural calcium oscillations using high-throughput fluorescence kinetics measurement system

    Sunao Hisada, Yiwen Wang, Du Shouming, Masanori Matsubara, Aoi Odawara, Ikuro Suzuki

     More details

  • ポスター賞

    2020.11   日本人工臓器学会   AI技術を用いた脱細胞化組織の分類と評価

    安田英莉、木村剛、橋本良秀、鈴木郁郎、中村奈緒子、岸田晶夫

     More details

  • 年会長賞

    2020.9   HAB研究機構   ヒト脳オルガノイドのMEA計測による痙攣陽性化合物の応答評価

    横井れみ、石橋 勇人、松田 直毅、小田原 あおい、鈴木 郁郎

     More details

  • 優秀研究発表賞

    2020.3   第11回安全性薬理研究会学術年会   薬理作用からけいれんリスクを直接示唆しない化合物に対するin vitro微小電極アレイ(MEA)を使用したけいれんリスク評価の事例研究

    岡村 愛、石橋 勇人、横井 れみ、木下 健一、白川 誉史、鈴木 郁郎

     More details

  • ライフサポート学会奨励賞

    2020.3   ライフサポート学会フロンティア講演会   ヒトiPS細胞由来ニューロンを用いた痙攣誘発毒性検出における最適なE/Iバランスの検討

    横井れみ、松田直毅、小田原あおい、鈴木郁郎

     More details

  • 優秀演題賞

    2019.11   第32回日本動物実験代替法学会   ヒトiPS細胞由来ニューロンにおける医薬品の痙攣リスクおよびMoAのAI予測

    松田直毅、小田原あおい、鈴木郁郎

     More details

  • 優秀ポスター賞

    2019.11   第10回スクリーニング学研究会   ヒトiPSC由来感覚ニューロンを用いたTRPチャネルの応答評価

    小田原あおい、松田直毅、鈴木郁郎

     More details

  • 大会長特別賞

    2019.11   第32回日本動物実験代替法学会   ヒトiPS細胞由来ニューロンにおける電気生理学的応答の多変量解析

    石橋勇人、小田原あおい、鈴木郁郎

     More details

  • Excellent Poster

    2019.10   The Chem-Bio Informatics Society   Evidence for the utility of human induced pluripotent stem cell-derived neurons in safety pharmacology-fact data indicating the achievement of network activities

    Kanako Takahashi, Kaori Chujo, Yasunari Kanda, Aoi Odawara, Ikuro Suzuki, Kaoru Sato

     More details

  • 優秀発表賞

    2019.1   第92回日本薬理学会   ヒトiPS細胞由来神経ネットワークにおける薬剤性痙攣毒性および作用機序推定を目指した主成分分析:HESI pilot study

    石橋勇人、小田原あおい、鈴木郁郎

     More details

  • 優秀研究発表賞

    2018.7   日本毒性学会   AIを用いたヒトiPS細胞由来ニューロンにおける痙攣毒性予測法の検討

    田直毅、小田原あおい、鈴木郁郎

     More details

  • ライフサポート学会奨励賞

    2018.3   ライフサポート学会フロンティア講演会   in vitroヒトiPS細胞由来神経ネットワークとin vivoヒト脳の痙攣発火を比較可能とする周波数解析

    石橋勇人、小田原あおい、鈴木郁郎

     More details

  • 優秀研究発表賞

    2017.7   日本毒性学会   MEAを用いたヒトiPS細胞由来感覚ニューロンのin vitro痛み応答計測

    小田原あおい、松田直毅、鈴木郁郎

     More details

  • 若手優秀講演フェロー賞

    2017.6   日本機械学会   Cell ball技術による接着細胞のダメージレスソーティング

    佐々木陽良、小田原あおい、鈴木郁郎

     More details

  • トーキン科学技術賞

    2017.3   トーキン財団   ヒトiPS細胞由来ニューロンの薬効評価系の構築

    鈴木郁郎

     More details

  • ライフサポート学会奨励賞

    2017.3   ライフサポート学会フロンティア講演会   ヒトiPS細胞由来ニューロン機能のエレクトロセンシング技術の開発

    松田直毅、小田原あおい、鈴木郁郎

     More details

  • 優秀研究発表賞

    2017.2   日本安全性薬理研究会   MEAシステムを用いたヒトiPS1細胞由来末梢ニューロンの痛み応答計測

    小田原あおい、飯田拓也、松田直毅、鈴木郁郎

     More details

  • ライフサポート学会奨励賞

    2015.3   ライフサポート学会   フローサイトメトリーへの応用を目指した微小神経ネットワークのゲルカプセル培養技術の開発

    佐々木陽良、佐藤伶、小田原あおい、稲生崇秀、川瀬芳恵、鈴木郁郎

     More details

  • 優秀発表賞

    2015.2   平成27年東北地区若手研究者研究発表会   微小神経ネットワークのゲルカプセル培養技術の開発

    佐々木陽良、佐藤玲、小田原あおい、稲生崇秀、川瀬芳恵、鈴木郁郎

     More details

  • 優秀発表賞

    2015.2   平成27年東北地区若手研究者研究発表会   培養神経ネットワークの長期活動におけるDFA解析

    加藤寛樹、小田原あおい、鈴木郁郎

     More details

  • 若手プレゼンテーション賞

    2012.11   LIFE2012生活生命支援医療福祉工学系学会連合大会   微小ナノカーボン電極を用いた細胞分泌物のリアルタイム計測技術の開発

    鈴木郁郎

     More details

  • 若手プレゼンテーション賞

    2011.11   AMBL2011生活生命支援医療福祉工学系学会連合大会   脳回路の3次元再構成技術と機能計測

    鈴木郁郎

     More details

  • 最優秀発表賞

    2008   東京医科歯科大学   IBB2008

    鈴木郁郎

     More details

  • 生物物理学会若手奨励賞

    2006.11   日本生物物理学会   Plasticity in single-cell-based reconstructed neuronal network pattern

    鈴木郁郎

     More details

  • Most Impressive Presentation

    2004.10   International Microprocesses and Nanotechnology Conference   Single-Cell-Based Re-Construction of Neuronal Network Using Agarose Microchamber

    Ikuro Suzuki, Yoshihiro Sugio, Yasuhiko Jimbo, Kenji Yasuda

     More details

▼display all

Research Projects

  • 細胞種を同定した数万ニューロンの1細胞発火パターンに基づく化合物評価基盤の開発

    Grant number:26K03267  2026.4 - 2029.3

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    鈴木 郁郎

      More details

    Grant amount:\24700000 ( Direct Cost: \19000000 、 Indirect Cost:\5700000 )

    researchmap

  • 高橋産業経済研究財団

    2018.1

      More details

Social Activities

  • 受託試験(民間企業)

    Role(s): Investigater

    民間企業  2023.4

     More details

    Type:Investigation, survey

    researchmap

  • 受託試験(民間企業)

    Role(s): Investigater

    民間企業  2023.2 - 2023.3

     More details

    Type:Investigation, survey

    researchmap

  • ヒトiPSC神経細胞及び脳オルガノイドの機能を指標とした医薬品の神経毒性予測および薬効評価への取り組み

    Role(s): Lecturer

    エーザイ株式会社  2022.12

     More details

    Type:Lecture

    researchmap

  • 受託試験(民間企業)

    Role(s): Investigater

    民間企業  2022.10 - 2023.4

     More details

    Type:Investigation, survey

    researchmap

  • 受託試験(民間企業)

    Role(s): Investigater

    民間企業  2022.8 - 2023.3

     More details

    Type:Investigation, survey

    researchmap

  • 受託試験(民間企業)

    Role(s): Investigater

    民間企業  2022.7 - 2022.11

     More details

    Type:Investigation, survey

    researchmap

  • ヒト神経細胞の創薬応用

    Role(s): Contribution

    公益財団法人 内藤記念科学振興財団  内藤財団時報 第98号  2016.1

     More details

    Type:Promotional material

    researchmap

  • 特集:創薬とバイオマテリアル「ヒトiPS細胞由来ニューロンの長期培養と薬効評価技術」

    Role(s): Contribution

    日本バイオマテリアル学会  バイオマテリアル-生体材料-33巻3号  2015.1

     More details

    Type:Promotional material

    researchmap

▼display all